MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Health Catalyst Accounts Receivables 2011-2026 | HCAT
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Health Catalyst
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.1 M | 57.2 M | 60.3 M | 48 M | 48.8 M | 48.3 M | 27.6 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.3 M | 27.6 M | 49.9 M |
Quarterly Accounts Receivables Health Catalyst
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.1 M | 68.4 M | 64 M | 57.2 M | - | - | - | 46.1 M | 48 M | - | - | 42.6 M | 48.8 M | 47.7 M | 47 M | 45.9 M | 48.3 M | 48.3 M | 48.3 M | 48.3 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.7 M | 27.7 M | 27.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 68.4 M | 27.6 M | 43.7 M |
Accounts Receivables of other stocks in the Health information services industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
9.11 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
733 M | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
1.16 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
49.7 M | $ 5.67 | -0.53 % | $ 91 M | USA |
 |
Computer Programs and Systems
CPSI
|
59.7 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
480 M | - | - | $ 2.94 B | USA |
 |
Teladoc Health
TDOC
|
193 M | $ 5.53 | -0.63 % | $ 975 M | USA |
 |
OptimizeRx Corporation
OPRX
|
36.3 M | $ 7.17 | -0.14 % | $ 123 M | USA |
 |
iCAD
ICAD
|
7.21 M | - | - | $ 102 M | USA |
 |
10x Genomics
TXG
|
115 M | $ 20.88 | -0.17 % | $ 2.45 B | USA |
 |
Evolent Health
EVH
|
269 M | $ 2.27 | 0.22 % | $ 213 M | USA |
 |
NextGen Healthcare
NXGN
|
77.5 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
103 M | - | - | $ 3.37 B | USA |
 |
MTBC
MTBC
|
15.1 M | - | -0.58 % | $ 51.7 M | USA |
 |
Zhongchao
ZCMD
|
10.3 M | $ 1.8 | - | $ 9.37 M |  China |
 |
Premier
PINC
|
99.1 M | - | - | $ 2.33 B | USA |
 |
GoodRx Holdings
GDRX
|
146 M | $ 2.07 | 0.49 % | $ 798 M | USA |
 |
SCWorx Corp.
WORX
|
373 K | $ 0.13 | 0.93 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
156 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
131 M | - | - | $ 3.81 B | USA |
 |
HealthStream
HSTM
|
30.2 M | $ 21.45 | 1.04 % | $ 652 M | USA |
 |
Akerna Corp.
KERN
|
486 K | - | - | $ 161 M | USA |
 |
Streamline Health Solutions
STRM
|
1.58 M | - | - | $ 21.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
327 M | - | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
5.95 M | - | -46.64 % | $ 10.4 M | USA |
 |
Omnicell
OMCL
|
256 M | $ 34.95 | 0.03 % | $ 1.61 B | USA |
 |
HealthEquity
HQY
|
124 M | $ 84.07 | 1.94 % | $ 7.24 B | USA |
 |
Phreesia
PHR
|
64.9 M | $ 11.72 | 4.27 % | $ 639 M | USA |
 |
Schrödinger
SDGR
|
83 M | $ 11.6 | 1.75 % | $ 852 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.3 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
235 M | $ 18.26 | 2.87 % | $ 1.57 B | USA |
 |
So-Young International
SY
|
52.9 M | $ 2.95 | -7.52 % | $ 234 M | China |
 |
Veeva Systems
VEEV
|
1.26 B | $ 181.52 | 1.93 % | $ 29.7 B | USA |